These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2244648)

  • 1. Neuroleptic malignant syndrome associated with withdrawal from carbamazepine.
    Keepers GA
    Am J Psychiatry; 1990 Dec; 147(12):1687. PubMed ID: 2244648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome secondary to loxapine.
    Chong LS; Abbott PM
    Br J Psychiatry; 1991 Oct; 159():572-3. PubMed ID: 1751872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome: case report and discussion.
    Chandran GJ; Mikler JR; Keegan DL
    CMAJ; 2003 Sep; 169(5):439-42. PubMed ID: 12952806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Neuroleptic malignant syndrome associated with quetiapine.
    Karagianis J; Phillips L; Hogan K; LeDrew K
    Can J Psychiatry; 2001 May; 46(4):370-1. PubMed ID: 11387795
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with carbamazepine.
    O'Griofa FM; Voris JC
    South Med J; 1991 Nov; 84(11):1378-80. PubMed ID: 1948228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal-induced neuroleptic malignant syndrome.
    Bower DJ; Chalasani P; Ammons JC
    Am J Psychiatry; 1994 Mar; 151(3):451-2. PubMed ID: 8109662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome after withdrawal of levopoda].
    Cedeno-Veloz B; Areosa Sastre A
    Rev Esp Geriatr Gerontol; 2018; 53(5):299-300. PubMed ID: 29628214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroleptic malignant-like syndrome following abrupt withdrawal of baclofen].
    Adeva-Bartolomé MT; Alonso-Navarro H; Martín-Prieto M; Jiménez-Jiménez FJ
    Med Clin (Barc); 2006 Jun; 127(2):79. PubMed ID: 16801014
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome and amantadine withdrawal.
    Lazarus A
    Am J Psychiatry; 1985 Jan; 142(1):142. PubMed ID: 3966578
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome and carbamazepine?
    van Amelsvoort T
    Br J Psychiatry; 1994 Feb; 164(2):269-70. PubMed ID: 8173838
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome, amitriptyline, and thioridazine.
    Corrigan FM; Coulter F
    Biol Psychiatry; 1988 Feb; 23(3):320-1. PubMed ID: 3337866
    [No Abstract]   [Full Text] [Related]  

  • 15. Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites.
    Burch EA; Goldschmidt TJ
    South Med J; 1983 Aug; 76(8):991-5. PubMed ID: 6879296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal.
    Tanii H; Fujita K; Okazaki Y
    Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome.
    Stonecipher A; Galang R; Black J
    Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of carbamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome.
    Nisijima K; Kusakabe Y; Ohtuka K; Ishiguro T
    Biol Psychiatry; 1998 Nov; 44(9):930-1. PubMed ID: 9807653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.